One can also anticipate a shift in treatment away from the exclusive emphasis on seizure control. We increasingly recognize that epilepsy is much more than seizures, and that patients with epilepsy may also have depression, impaired memory, and anxiety related to their illness. In the long run, the psychosocial problems of patients with epilepsy cannot be separated from social problems as a whole. Will, for example, the new, and doubtless expensive, treatments for epilepsy be made available to all who need them, or will we be obliged to work in a two-tier system? As health care providers, we can be cautiously optimistic regarding the medical aspects of epilepsy, but we will have to think in quite unanticipated ways to ensure equitable outcomes.
Recommended Reading
Conference Coverage
-
Noninvasive testing in midlife flags late-onset epilepsy risk -
Novel neural cell therapy: A cure for focal epilepsy? Publish date: April 24, 2023 -
Seizures in dementia hasten decline and death Publish date: December 14, 2022 -
Three antiseizure medications join list for newborn risks Publish date: December 13, 2022 -
‘Striking’ rate of mental health comorbidities in epilepsy Publish date: December 12, 2022 -
Significant racial disparities persist in status epilepticus Publish date: December 12, 2022 -
Study implicates myelin plasticity in absence seizures Publish date: December 9, 2022 -
Newer brand-name drugs fuel spending on antiseizure medications -
Diazepam nasal spray effective in Lennox-Gastaut syndrome Publish date: October 24, 2022 -
Antiseizure medication appears safe in pregnancy
Multimedia
-
Patients describe significant impact of epilepsy on their lives -
Tatiana Falcone, MD Publish date: December 18, 2017 -
Andrew G. Herzog, MD Publish date: December 18, 2017
Literature Review
-
Minorities with epilepsy blocked from receiving ‘highest quality of care’ -
Modified Atkins diet beneficial in drug-resistant epilepsy -
Antiepileptic drugs tied to increased Parkinson’s disease risk -
Strong two-way link between epilepsy and depression Publish date: December 6, 2022 -
High drug costs exclude most neurology patients from cutting-edge treatment -
Drug-resistant epilepsy needs earlier surgical referral -
‘Striking’ jump in cost of brand-name epilepsy meds -
Air pollution is a seizure trigger for patients with epilepsy -
New guidance on cannabis use for treatment-resistant epilepsy -
ILAE offers first guide to treating depression in epilepsy
Neurobehavioral comorbidities of epilepsy
Question 1 of 5